Document is current
Any future updates will be listed below
-
Authors
Ma, Yuxiang https://orcid.org/0000-0003-1173-8441
Yang, Yunpeng
Huang, Yan
Fang, Wenfeng
Xue, Jinhui
Meng, Xiangjiao
Fan, Yun https://orcid.org/0000-0003-1755-0175
Fu, Siqing https://orcid.org/0000-0002-1933-0419
Wu, Lin https://orcid.org/0000-0001-7078-7767
Zheng, Yulong
Liu, Jian
Liu, Zhihua
Zhuang, Wu
Rosen, Seth
Qu, Song
Li, Bihui
Li, Mingjun
Zhao, Yanqiu
Yang, Shujun
Ji, Yinghua
Sommerhalder, David https://orcid.org/0000-0002-7033-9064
Luo, Suxia
Yang, Kunyu
Li, Jingao
Lv, Dongqing
Zhang, Peng
Zhao, Yuanyuan
Hong, Shaodong
Zhang, Yang
Zhao, Shen
Chin, Steve
Zhang, Xian
Lian, Wei https://orcid.org/0009-0003-8415-6001
Cai, Jiaqiang
Xue, Tongtong https://orcid.org/0009-0000-5961-7724
Zhang, Li https://orcid.org/0000-0003-0595-0761
Zhao, Hongyun https://orcid.org/0000-0002-1251-3888
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82473346, 82272789)
Guangzhou Science &Technology Project
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 20 February 2025
First Online: 13 March 2025
Competing interests
: L.Z. reports receiving research support from AstraZeneca, Akeso Biopharma, Bristol Myers Squibb, Chia Tai Tianqing Pharmaceutical Group, Junshi Pharmaceuticals, QiLu Pharmaceutical and Pfizer. S.C., X.Z., W.L., J.C. and T.X. are employees of MediLink Therapeutics. The other authors declare no competing interests.
